Silexion Therapeutics Corp Company Profile
NASDAQ: SLXNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 3:42 PM ET
Silexion Therapeutics at a glance
Silexion Therapeutics Corp (NASDAQ: SLXN) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Jerusalem, Israel. Silexion Therapeutics is led by Mr. Ilan Hadar M.B.A. and employs about 13 people. At a market capitalization of $3.4 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0002022416, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Silexion Therapeutics do?
Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.
Business description based on the company's public filings.
Company information
- Legal name
- Silexion Therapeutics Corp
- Ticker
- NASDAQ: SLXN
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Ilan Hadar M.B.A.
- Employees
- 13
- Headquarters
- The Goldyne Savad Inst. of Gene Therapy, Jerusalem, Israel
- Phone
- 972 2 674 3430
- Website
- silexion.com
- Market cap
- $3.40M
- SEC CIK
- 0002022416
Companies similar to Silexion Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VIVSVivoSim Labs Inc. | 0.183 | +3.27% | $3.04M | vs SLXN |
| CLDICalidi Biotherapeutics Inc. | 1.05 | +0.96% | $3.86M | vs SLXN |
| HLSQTessera Defense and Homeland Security Inc. | 0.2973 | +1.99% | $2.68M | vs SLXN |
| PMCBPharmaCyte Biotech Inc. | 0.4149 | +2.79% | $4.45M | vs SLXN |
| LIMNLiminatus Pharma Inc. Class A | 3.73 | +0.95% | $5.00M | vs SLXN |
| CRISCuris Inc. | 0.6669 | -5.99% | $1.62M | vs SLXN |
| SCNIScinai Immunotherapeutics Ltd. ADR | 1.19 | -1.65% | $1.61M | vs SLXN |
| CELZCreative Medical Technology Holdings Inc. | 0.8299 | -3.53% | $6.30M | vs SLXN |